Commerzbank Aktiengesellschaft’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,247
| Closed | -$561K | – | 451 |
|
|
2020
Q1 | $561K | Sell |
6,247
-14,200
| -69% | -$1.39M | 0.03% | 251 |
|
|
2019
Q4 | $2.21M | Sell |
20,447
-128,587
| -86% | -$13.8M | 0.02% | 324 |
|
|
2019
Q3 | $14.6M | Buy |
149,034
+13,237
| +10% | +$1.49M | 0.11% | 151 |
|
|
2019
Q2 | $17.8M | Buy |
135,797
+12,474
| +10% | +$1.61M | 0.15% | 126 |
|
|
2019
Q1 | $16.7M | Sell |
123,323
-95,365
| -44% | -$11.9M | 0.15% | 122 |
|
|
2018
Q4 | $21.3M | Buy |
218,688
+125,344
| +134% | +$14.8M | 0.22% | 87 |
|
|
2018
Q3 | $13M | Sell |
93,344
-5,433
| -6% | -$682K | 0.11% | 152 |
|
|
2018
Q2 | $12.3M | Sell |
98,777
-12,648
| -11% | -$1.48M | 0.12% | 154 |
|
|
2018
Q1 | $12.4M | Sell |
111,425
-37,914
| -25% | -$4.53M | 0.13% | 153 |
|
|
2017
Q4 | $17.9M | Sell |
149,339
-431
| -0.3% | -$52.5K | 0.21% | 101 |
|
|
2017
Q3 | $21M | Buy |
149,770
+17,072
| +13% | +$2.32M | 0.28% | 85 |
|
|
2017
Q2 | $16.1M | Buy |
132,698
+79,943
| +152% | +$9.3M | 0.28% | 89 |
|
|
2017
Q1 | $6.4M | Buy |
52,755
+40,916
| +346% | +$5.28M | 0.1% | 183 |
|
|
2016
Q4 | $1.45M | Buy |
11,839
+7,416
| +168% | +$907K | 0.02% | 379 |
|
|
2016
Q3 | $542K | Sell |
4,423
-6,942
| -61% | -$894K | 0.01% | 548 |
|
|
2016
Q2 | $1.33K | Sell |
11,365
-9,243
| -45% | -$1.31M | 0.01% | 430 |
|
|
2016
Q1 | $2.87M | Sell |
20,608
-61,759
| -75% | -$9.07M | 0.02% | 315 |
|
|
2015
Q4 | $15.7M | Buy |
82,367
+1,285
| +2% | +$224K | 0.14% | 140 |
|
|
2015
Q3 | $12.7M | Sell |
81,082
-51,247
| -39% | -$9.35M | 0.11% | 142 |
|
|
2015
Q2 | $23.9M | Buy |
132,329
+4,475
| +4% | +$772K | 0.13% | 112 |
|
|
2015
Q1 | $22.2M | Buy |
127,854
+2,136
| +2% | +$387K | 0.15% | 117 |
|
|
2014
Q4 | $23.3M | Sell |
125,718
-10,770
| -8% | -$2M | 0.17% | 115 |
|
|
2014
Q3 | $22.6M | Buy |
136,488
+23,831
| +21% | +$3.91M | 0.1% | 174 |
|
|
2014
Q2 | $17.6M | Buy |
112,657
+8,928
| +9% | +$1.41M | 0.1% | 178 |
|
|
2014
Q1 | $15.8M | Sell |
103,729
-2,653
| -2% | -$422K | 0.07% | 181 |
|
|
2013
Q4 | $16.9M | Sell |
106,382
-20,815
| -16% | -$2.5M | 0.09% | 164 |
|
|
2013
Q3 | $14.8M | Buy |
127,197
+3,155
| +3% | +$346K | 0.08% | 204 |
|
|
2013
Q2 | $11.4M | Buy |
+124,042
| New | +$12M | 0.05% | 284 |
|
Other funds holding ALXN
BBA
